EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Optimal radiotherapy dose and fractionation for stereotactic radiotherapy in excised brain metastases

Kelvin Cheuk Man Cheung, Gavin Tin Chun Cheung, Ka Man Cheung, James Chung Hang Chow, Kwok Hung Au

Radiation Oncology Journal · 30.06.2025 · 43 (2) · 79-87

DOI: 10.3857/roj.2024.00556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiation Oncology Journal, erschienen am 30.06.2025. Verfasst von Kelvin Cheuk Man Cheung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, Hong Kong. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Stereotactic radiotherapy (SRT) is an important adjunctive treatment after excision of brain metastases. We investigated efficacy and safety outcomes of such treatment and the impact of radiotherapy dose fractionations in a real-world multi-center cohort.Materials and Methods: All patients who received resection cavity SRT between 2018–2022 were identified from institutional databases of two tertiary oncology centers. Patient and treatment characteristics were summarized using descriptive statistics. Local control rate (LCR), distant brain control rate (DBCR), and overall survival (OS) were estimated. Prognostic factors were investigated using univariate/multivariate Cox regression. The incidence of radiation necrosis (RN) was reported.

Results

Sixty-five cavities were analyzed. The most used SRT prescription was 30 Gy/5 fractions. One-year LCR, DBCR, and OS were 69.0%, 51.9%, and 71.0%, respectively. BED10 (biological effective dose using α/β ratio of 10) was a significant factor for improved local control on both univariate (hazard ratio [HR], 0.862; 95% confidence interval [CI], 0.787 to 0.944; p = 0.001) and multivariate analysis (HR, 0.890; 95% CI, 0.803 to 0.986; p = 0.026). Cavities prescribed BED10 ≥45 Gy had superior local control than those prescribed BED10

Schlagwörter

Stichwörter der Autor:innen

Brain neoplasmsNecrosisRadiation dose fractionation

Autor:innen und Institutionen

  • Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, Hong Kong.
  • Department of Oncology, United Christian Hospital, Hong Kong, Hong Kong.

Zitieren

APA

Cheung, K. C. M., Cheung, G. T. C., Cheung, K. M., Chow, J. C. H., & Au, K. H. (2025). Optimal radiotherapy dose and fractionation for stereotactic radiotherapy in excised brain metastases. Radiation Oncology Journal, 43(2), 79-87. https://doi.org/10.3857/roj.2024.00556

Vancouver

Cheung KCM, Cheung GTC, Cheung KM, Chow JCH, Au KH. Optimal radiotherapy dose and fractionation for stereotactic radiotherapy in excised brain metastases. Radiation Oncology Journal. 2025;43(2):79-87. doi:10.3857/roj.2024.00556

BibTeX
@article{Cheung2025,
  author = {Cheung, Kelvin Cheuk Man and Cheung, Gavin Tin Chun and Cheung, Ka Man and Chow, James Chung Hang and Au, Kwok Hung},
  title = {Optimal radiotherapy dose and fractionation for stereotactic radiotherapy in excised brain metastases},
  journal = {Radiation Oncology Journal},
  year = {2025},
  volume = {43},
  number = {2},
  pages = {79--87},
  doi = {10.3857/roj.2024.00556}
}
Kostenlos starten →